Tag Archives: BGCP

Top 10 Value Stocks To Buy Right Now

Marcus & Millichap Inc (NYSE:MMI) major shareholder Phoenix Investments Holdings L sold 3,000 shares of Marcus & Millichap stock in a transaction that occurred on Monday, July 30th. The shares were sold at an average price of $40.27, for a total transaction of $120,810.00. Following the completion of the transaction, the insider now directly owns 16,532,215 shares in the company, valued at approximately $665,752,298.05. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Major shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Phoenix Investments Holdings L also recently made the following trade(s):

Top 10 Value Stocks To Buy Right Now: Scana Corporation(SCG)

Advisors’ Opinion:

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Wednesday was SCANA Corp. (NYSE: SCG) which rose over 22% to $47.71. The stock’s 52-week range is $37.10 to $73.81. Volume was about 19 million compared to its average volume of 2 million.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Tuesday was SCANA Corp. (NYSE: SCG) which traded down roughly 5% at $41.13. The stock’s 52-week range is $37.10 to $71.28. Volume was 3.5 million, compared with the daily average of 3 million shares.

  • [By Matthew Frankel, CFP®, Neha Chamaria, and Matthew DiLallo]

    Granted, Dominion Energy’s payout of around 70% is at the higher end, but it shouldn’t be tough for the utility to maintain dividends given the highly regulated nature of its revenue. Of late, the market has been concerned about a couple of developments, including Dominion’s impending acquisition of SCANA Corp. (NYSE: SCG) and its planned funding route that is now in the reworks because of regulatory changes.

  • [By Lisa Levin] Companies Reporting Before The Bell
    General Motors Company (NYSE: GM) is projected to report quarterly earnings at $1.24 per share on revenue of $34.66 billion.
    Bristol-Myers Squibb Company (NYSE: BMY) is estimated to report quarterly earnings at $0.85 per share on revenue of $5.24 billion.
    United Parcel Service, Inc. (NYSE: UPS) is expected to report quarterly earnings at $1.55 per share on revenue of $16.44 billion.
    Time Warner Inc. (NYSE: TWX) is projected to report quarterly earnings at $1.74 per share on revenue of $7.91 billion.
    ConocoPhillips (NYSE: COP) is expected to report quarterly earnings at $0.74 per share on revenue of $8.81 billion.
    PepsiCo, Inc. (NYSE: PEP) is expected to report quarterly earnings at $0.93 per share on revenue of $12.4 billion.
    American Airlines Group Inc. (NASDAQ: AAL) is estimated to report quarterly earnings at $0.72 per share on revenue of $10.42 billion.
    Southwest Airlines Co (NYSE: LUV) is expected to report quarterly earnings at $0.74 per share on revenue of $5.01 billion.
    Fiat Chrysler Automobiles N.V. (NYSE: FCAU) is estimated to report quarterly earnings at $0.8 per share on revenue of $34.52 billion.
    Union Pacific Corporation (NYSE: UNP) is projected to report quarterly earnings at $1.66 per share on revenue of $5.38 billion.
    D.R. Horton, Inc. (NYSE: DHI) is expected to report quarterly earnings at $0.85 per share on revenue of $3.76 billion.
    The Hershey Company (NYSE: HSY) is estimated to report quarterly earnings at $1.4 per share on revenue of $1.94 billion.
    Praxair, Inc. (NYSE: PX) is expected to report quarterly earnings at $1.56 per share on revenue of $2.94 billion.
    Altria Group, Inc. (NYSE: MO) is projected to report quarterly earnings at $0.92 per share on revenue of $4.63 billion.
    Shire plc (NASDAQ: SHPG) is estimated to report quarterly earnings at $3.54 per share on revenue of $3.72 billion.
    Oshkosh Corporation (NYSE: OSK) is projected to report quarter
  • [By Shane Hupp]

    Teacher Retirement System of Texas cut its stake in shares of SCANA Co. (NYSE:SCG) by 8.3% in the second quarter, HoldingsChannel.com reports. The fund owned 27,484 shares of the utilities provider’s stock after selling 2,503 shares during the period. Teacher Retirement System of Texas’ holdings in SCANA were worth $1,059,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Shane Hupp]

    Shares of SCANA Co. (NYSE:SCG) have received a consensus recommendation of “Hold” from the twelve research firms that are currently covering the company, Marketbeat reports. Three investment analysts have rated the stock with a sell recommendation, six have issued a hold recommendation and two have issued a buy recommendation on the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $43.75.

Top 10 Value Stocks To Buy Right Now: PDF Solutions Inc.(PDFS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    These are some of the media headlines that may have effected Accern Sentiment’s scoring:

    Get PDF Solutions alerts:

    FlipHTML5 Page Flip PDF Turns Social Media Accounts Into Compelling Ones (digitaljournal.com) $23.10 Million in Sales Expected for PDF Solutions, Inc. (PDFS) This Quarter (americanbankingnews.com) PDF Solutions, Inc. (PDFS) Expected to Announce Earnings of $0.06 Per Share (americanbankingnews.com) Basware introduces a ‘Smart PDF’ invoice (itwire.com) ActivePDF Brings Redaction to Businesses, Improving Privacy, Security,… (virtual-strategy.com)

    A number of equities research analysts have recently commented on PDFS shares. Zacks Investment Research cut shares of PDF Solutions from a “hold” rating to a “sell” rating in a report on Wednesday, May 16th. DA Davidson cut their price target on shares of PDF Solutions to $26.00 and set a “buy” rating on the stock in a report on Friday, February 16th. BidaskClub upgraded shares of PDF Solutions from a “strong sell” rating to a “sell” rating in a report on Thursday, May 3rd. Finally, ValuEngine cut shares of PDF Solutions from a “hold” rating to a “sell” rating in a report on Friday, February 2nd. Two equities research analysts have rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $22.00.

  • [By Motley Fool Transcribers]

    PDF Solutions Inc  (NASDAQ:PDFS)Q4 2018 Earnings Conference CallFeb. 14, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    ValuEngine upgraded shares of PDF Solutions (NASDAQ:PDFS) from a strong sell rating to a sell rating in a report released on Tuesday.

    PDFS has been the topic of a number of other research reports. Zacks Investment Research upgraded PDF Solutions from a sell rating to a hold rating in a research report on Wednesday, March 14th. BidaskClub upgraded PDF Solutions from a sell rating to a hold rating in a research report on Wednesday, May 9th. Finally, DA Davidson reduced their price objective on PDF Solutions to $26.00 and set a buy rating on the stock in a research report on Friday, February 16th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the company. The company presently has a consensus rating of Hold and an average target price of $22.00.

Top 10 Value Stocks To Buy Right Now: ADTRAN Inc.(ADTN)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of ADTRAN, Inc. (NASDAQ:ADTN) saw unusually-strong trading volume on Friday . Approximately 1,051,552 shares were traded during trading, an increase of 134% from the previous session’s volume of 450,057 shares.The stock last traded at $18.60 and had previously closed at $18.50.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on ADTRAN (ADTN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    ADTRAN (NASDAQ: ADTN) and One Horizon Group (NASDAQ:OHGI) are both small-cap computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability and analyst recommendations.

  • [By Shane Hupp]

    BidaskClub upgraded shares of ADTRAN (NASDAQ:ADTN) from a hold rating to a buy rating in a research note issued to investors on Thursday.

    Several other analysts have also issued reports on ADTN. Zacks Investment Research upgraded shares of ADTRAN from a hold rating to a buy rating and set a $19.00 price target on the stock in a research report on Tuesday, October 9th. Needham & Company LLC decreased their price target on shares of ADTRAN from $18.00 to $17.00 and set a buy rating on the stock in a research report on Thursday, October 18th. They noted that the move was a valuation call. ValuEngine lowered shares of ADTRAN from a buy rating to a hold rating in a research report on Wednesday, October 17th. Northland Securities set a $24.00 price target on shares of ADTRAN and gave the stock a buy rating in a research report on Thursday, December 20th. Finally, MKM Partners decreased their price target on shares of ADTRAN to $17.00 and set a buy rating on the stock in a research report on Thursday, December 20th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and four have issued a buy rating to the company’s stock. The company currently has a consensus rating of Hold and an average target price of $17.50.

  • [By Max Byerly]

    ADTRAN, Inc. (NASDAQ:ADTN) has been assigned an average rating of “Hold” from the eleven ratings firms that are covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and three have given a buy recommendation to the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is $19.38.

Top 10 Value Stocks To Buy Right Now: U.S. Bancorp(USB)

Advisors’ Opinion:

  • [By Todd Campbell]

    Warren Buffett’s penchant for picking great stocks for Berkshire Hathaway’s (NYSE:BRK-A) (NYSE:BRK-B) portfolio makes his quarterly stock picks must-know news for every long-term investor. Luckily, Buffett is required to file a 13F report with the Securities and Exchange Commission every quarter showing what he’s been buying, and that makes following in his footsteps easier. Last quarter, his top buys were U.S. Bancorp (NYSE:USB), Apple, Inc. (NASDAQ:AAPL), and Teva Pharmaceutical Industries (NYSE:TEVA). Should you buy these stocks for your portfolio, too?

  • [By Ethan Ryder]

    Indiana Trust & Investment Management CO acquired a new stake in U.S. Bancorp (NYSE:USB) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 14,613 shares of the financial services provider’s stock, valued at approximately $731,000.

  • [By Shane Hupp]

    Investors bought shares of U.S. Bancorp (NYSE:USB) on weakness during trading on Friday. $366.36 million flowed into the stock on the tick-up and $39.37 million flowed out of the stock on the tick-down, for a money net flow of $326.99 million into the stock. Of all stocks tracked, U.S. Bancorp had the 21st highest net in-flow for the day. U.S. Bancorp traded down ($0.21) for the day and closed at $55.14

  • [By Shane Hupp]

    ValuEngine lowered shares of U.S. Bancorp (NYSE:USB) from a hold rating to a sell rating in a research note issued to investors on Monday.

    Several other analysts also recently commented on USB. Susquehanna Bancshares set a $57.00 target price on U.S. Bancorp and gave the company a hold rating in a research note on Monday, April 23rd. Keefe, Bruyette & Woods reiterated a hold rating and set a $56.00 price target on shares of U.S. Bancorp in a research note on Thursday, April 5th. Citigroup upgraded U.S. Bancorp from a neutral rating to a buy rating and set a $58.00 price target for the company in a research note on Friday, May 11th. Morgan Stanley cut their price target on U.S. Bancorp from $61.00 to $57.00 and set an underweight rating for the company in a research note on Thursday, April 19th. Finally, Vining Sparks reiterated a buy rating and set a $61.00 price target on shares of U.S. Bancorp in a research note on Friday, April 6th. Five analysts have rated the stock with a sell rating, ten have issued a hold rating and nine have assigned a buy rating to the stock. U.S. Bancorp presently has a consensus rating of Hold and a consensus target price of $58.38.

  • [By Joseph Griffin]

    Twin Tree Management LP trimmed its holdings in shares of U.S. Bancorp (NYSE:USB) by 89.9% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,301 shares of the financial services provider’s stock after selling 20,453 shares during the period. Twin Tree Management LP’s holdings in U.S. Bancorp were worth $116,000 as of its most recent SEC filing.

Top 10 Value Stocks To Buy Right Now: CRB Futures Index(CR)

Advisors’ Opinion:

  • [By Shane Hupp]

    DA Davidson set a $111.00 price target on Crane (NYSE:CR) in a research report released on Friday. The brokerage currently has a buy rating on the conglomerate’s stock.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Crane (CR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Crew Energy (TSE:CR) had its price objective lowered by equities research analysts at Canaccord Genuity from C$4.50 to C$4.00 in a report issued on Tuesday. Canaccord Genuity’s price objective indicates a potential upside of 101.01% from the stock’s previous close.

Top 10 Value Stocks To Buy Right Now: Endocyte, Inc.(ECYT)

Advisors’ Opinion:

  • [By Keith Speights]

    Shares of Innovate Biopharmaceuticals (NASDAQ:INNT), Arrowhead Pharmaceuticals (NASDAQ:ARWR), and Endocyte (NASDAQ:ECYT) have more than tripled in the first six months of 2018. What caused these biotech stocks to skyrocket — and are they still buys now?  

  • [By Joseph Griffin]

    Endocyte (NASDAQ:ECYT) is set to release its earnings data after the market closes on Monday, May 7th. Analysts expect Endocyte to post earnings of ($0.19) per share for the quarter.

  • [By ]

    Exploding biotech names are nothing new to this bull market. You might recall the headline swirling around Endocyte Inc. (NASDAQ:ECYT) as it posted one-day gains of more than 150% during the fourth quarter. The triple-digit move was sparked by a licensing agreement for the firm’s phase 3 prostate cancer drug. Now, these moves are becoming almost commonplace.

  • [By Logan Wallace]

    Endocyte, Inc. (NASDAQ:ECYT) gapped up prior to trading on Tuesday . The stock had previously closed at $16.70, but opened at $18.00. Endocyte shares last traded at $19.49, with a volume of 145358 shares changing hands.

  • [By Chris Lange]

    Endocyte Inc. (NASDAQ: ECYT) filed with the U.S. Securities and Exchange Commission (SEC) for a secondary offering. In most cases where a company does this, we see the stock drop. However, in this case investors are cheering Endocyte and its secondary offering.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Endocyte (ECYT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Value Stocks To Buy Right Now: BGC Partners, Inc.(BGCP)

Advisors’ Opinion:

  • [By Logan Wallace]

    LPL Financial (NASDAQ: LPLA) and BGC Partners (NASDAQ:BGCP) are both mid-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, earnings, dividends and profitability.

  • [By ]

    BGC Partners (BGCP) : “We’re in a market where Goldman Sachs (GS) got slammed. I’m going with them.”

    Ecolab (ECL) : “That’s a terrific situation that I want you to buy more of if it comes down.”

  • [By ]

    Cramer was bearish on BGC Partners (BGCP) , Dr Pepper Snapple (DPS) , Sterling Construction Co. Inc.  (STRL) and B&G Foods (BGS) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

Top 10 Value Stocks To Buy Right Now: AxoGen, Inc.(AXGN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    State Board of Administration of Florida Retirement System boosted its holdings in AxoGen, Inc Common Stock (NASDAQ:AXGN) by 17.8% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 23,103 shares of the medical equipment provider’s stock after buying an additional 3,490 shares during the quarter. State Board of Administration of Florida Retirement System owned 0.06% of AxoGen, Inc Common Stock worth $1,161,000 at the end of the most recent quarter.

  • [By Max Byerly]

    AxoGen, Inc Common Stock (NASDAQ:AXGN) – Investment analysts at Leerink Swann raised their FY2019 EPS estimates for shares of AxoGen, Inc Common Stock in a research report issued to clients and investors on Tuesday, August 21st. Leerink Swann analyst R. Newitter now forecasts that the medical equipment provider will earn ($0.39) per share for the year, up from their prior forecast of ($0.41). Leerink Swann currently has a “Outperform” rating and a $70.00 target price on the stock.

  • [By Joseph Griffin]

    These are some of the media stories that may have impacted Accern’s analysis:

    Get AxoGen alerts:

    Analysts Anticipate AxoGen, Inc (AXGN) Will Announce Earnings of -$0.06 Per Share (americanbankingnews.com) The SVP Sales of AxoGen (NASDAQ: AXGN) is Selling Shares (analystratings.com) BRIEF-Axogen Inc Says On May 15, Board Elected CEO Zaderej To Succeed Grooms As Chairman (reuters.com) AxoGen, Inc (AXGN) SVP Shawn F. Mccarrey Sells 10,000 Shares (americanbankingnews.com) Global Nerve Repair Biomateria Market Report 2018-2023 -Axogen, Integra, Synovis, Collagen Matrix, Polyganics … (talkdailynews.com)

    AxoGen opened at $43.95 on Monday, Marketbeat reports. AxoGen has a fifty-two week low of $13.95 and a fifty-two week high of $46.00. The company has a debt-to-equity ratio of 0.82, a quick ratio of 2.81 and a current ratio of 3.32. The company has a market cap of $1.52 billion, a P/E ratio of -141.77 and a beta of -0.04.

Top 10 Value Stocks To Buy Right Now: Lowe’s Companies Inc.(LOW)

Advisors’ Opinion:

  • [By Jason Hall]

    Douglass: Right. Let’s talk briefly about, we’ve talked about the home sector as this big thing. Let’s break that down a little bit, what the kind of general different ways of thinking about an approach in the home sector are. Obviously, you’ve got your direct homebuilders. We’ll get more into specifics on all these after the break. You’ve got your home builders, the folks who actually build homes. You’ve also got the Home Depots (NYSE:HD) and Lowe’s (NYSE:LOW) of the world, who are good about the home maintenance and things like that. That’s been another big part. Then you also have …

  • [By Matthew DiLallo]

    Image source: Getty Images.

    Two case studies in dividend growth investing: 1. Lowes (NYSE:LOW)

    To illustrate the power of dividend growth stocks, we’ll take a closer look at a home improvement giant Lowes, which has an impressive dividend history. The company, which has paid dividends since it came public in 1961, has earned the title of Dividend King after having raised its payout for 54 consecutive years. That steadily growing dividend has helped Lowes vastly outperform the S&P 500. Over the last decade alone, Lowes produced a total return of more than 315% while the S&P 500’s total return has been just over 135%.

  • [By Demitrios Kalogeropoulos]

    Unlike rival Lowe’s (NYSE:LOW), Home Depot is done expanding its store base, and so its comparable-store sales metric, describing sales at existing locations, is the key growth figure to follow. That rate is expected to slow to about 5% in 2018 from last year’s scorching 7% result. But management may update that target on Tuesday to reflect the latest demand trends. Lowe’s current forecast calls for a more modest 3.5% comps improvement this year.

  • [By Shane Hupp]

    Mckinley Capital Management LLC Delaware acquired a new stake in Lowe’s (NYSE:LOW) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 40,076 shares of the home improvement retailer’s stock, valued at approximately $3,517,000.

Top 10 Value Stocks To Buy Right Now: SPDR Dow Jones Industrial Average ETF (DIA)

Advisors’ Opinion:

  • [By Shane Hupp]

    GenWealth Group Inc. grew its position in SPDR Dow Jones Industrial Average ETF Trust (NYSEARCA:DIA) by 1.4% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 44,725 shares of the exchange traded fund’s stock after acquiring an additional 639 shares during the quarter. SPDR Dow Jones Industrial Average ETF Trust accounts for about 5.5% of GenWealth Group Inc.’s holdings, making the stock its 9th largest position. GenWealth Group Inc. owned 0.05% of SPDR Dow Jones Industrial Average ETF Trust worth $11,967,000 at the end of the most recent reporting period.

  • [By Dustin Parrett]

    If you put $10,000 of your retirement savings into the SPDR Dow Jones Industrial Average ETF (NYSE Arca: DIA) in March 2009, you’d be sitting on $34,447 today.

  • [By Money Morning Staff Reports]

    Through Tom’s various strategies, followers had the chance to pocket gains of 195.36% in 16 days on Priceline Group Inc. (Nasdaq: PCLN), 193.39% in 16 days on SPDR Gold Trust (ETF) (NYSE Arca: GLD), 100% in eight days on International Business Machines Corp. (NYSE: IBM), and even 248.42% in 17 days on SPDR Dow Jones Industrial Average ETF (NYSE Arca: DIA).

  • [By Shane Hupp]

    Traders bought shares of SPDR Dow Jones Industrial Average ETF Trust (NYSEARCA:DIA) on weakness during trading hours on Thursday. $242.64 million flowed into the stock on the tick-up and $212.95 million flowed out of the stock on the tick-down, for a money net flow of $29.69 million into the stock. Of all companies tracked, SPDR Dow Jones Industrial Average ETF Trust had the 29th highest net in-flow for the day. SPDR Dow Jones Industrial Average ETF Trust traded down ($0.64) for the day and closed at $255.16

  • [By Shane Hupp]

    Dynamic Advisor Solutions LLC lessened its position in SPDR Dow Jones Industrial Average ETF Trust (NYSEARCA:DIA) by 90.5% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 1,526 shares of the exchange traded fund’s stock after selling 14,566 shares during the period. Dynamic Advisor Solutions LLC’s holdings in SPDR Dow Jones Industrial Average ETF Trust were worth $368,000 as of its most recent filing with the SEC.

  • [By Todd Shriber, ETF Professor]

    Year-to-date, the SPDR Dow Jones Industrial Average ETF (NYSE: DIA), the largest exchange traded fund tracking the Dow, is up 0.6 percent, including dividends paid.

Hot Clean Energy Stocks To Buy Right Now

What happened 

Shares of natural gas fuel company Clean Energy Fuels Corp (NASDAQ:CLNE) fell as much as 17.8% in trading Thursday, ending the day down 15.5% as an analyst gave a negative review of the stock. But keep in mind that shares are still up 54.2% year to date, so this has been a winner of late for investors. 

So what

Today’s move was driven by Raymond James analyst Pavel Molchanov, who cut his rating from market perform to underperform. Excitement about the equity investment Total made in the company earlier this year was cited as a reason shares have surged, but Molchanov thinks shares have gone up too high too fast.

Image source: Getty Images.

Shares of Clean Energy Fuels have been very volatile this year, but they’ve been rising on news like the Total investment and rising oil prices. On the flip side, the company has actually been shrinking, and losses have been growing over the past year, so fundamentals haven’t caught up to investor bullishness at the moment. 

Hot Clean Energy Stocks To Buy Right Now: BGC Partners, Inc.(BGCP)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on BGC Partners (BGCP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    LPL Financial (NASDAQ: LPLA) and BGC Partners (NASDAQ:BGCP) are both mid-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, earnings, dividends and profitability.

  • [By ]

    BGC Partners (BGCP) : “We’re in a market where Goldman Sachs (GS) got slammed. I’m going with them.”

    Ecolab (ECL) : “That’s a terrific situation that I want you to buy more of if it comes down.”

  • [By Logan Wallace]

    DEUTSCHE BOERSE/ADR (OTCMKTS: DBOEY) and BGC Partners (NASDAQ:BGCP) are both finance companies, but which is the better business? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership.

Hot Clean Energy Stocks To Buy Right Now: Castle (A.M.) & Co.(CAS)

Advisors’ Opinion:

  • [By Max Byerly]

    Cashaa (CURRENCY:CAS) traded 5.4% lower against the U.S. dollar during the 1-day period ending at 17:00 PM Eastern on June 26th. Cashaa has a total market capitalization of $14.70 million and $413,446.00 worth of Cashaa was traded on exchanges in the last 24 hours. One Cashaa token can now be bought for approximately $0.0354 or 0.00000572 BTC on popular exchanges including HitBTC and IDEX. During the last week, Cashaa has traded down 17.6% against the U.S. dollar.

  • [By Joseph Griffin]

    Cascades Inc (TSE:CAS) – Analysts at National Bank Financial raised their Q4 2018 earnings per share (EPS) estimates for Cascades in a report issued on Thursday, August 9th. National Bank Financial analyst L. Aghazarian now expects that the company will post earnings of $0.28 per share for the quarter, up from their previous estimate of $0.26. National Bank Financial has a “Outperform” rating and a $18.00 price target on the stock.

  • [By Joseph Griffin]

    Cashaa (CURRENCY:CAS) traded up 3% against the US dollar during the 1 day period ending at 23:00 PM E.T. on September 18th. During the last seven days, Cashaa has traded 2.5% lower against the US dollar. Cashaa has a market capitalization of $6.33 million and $110,922.00 worth of Cashaa was traded on exchanges in the last day. One Cashaa token can currently be purchased for approximately $0.0124 or 0.00000195 BTC on popular cryptocurrency exchanges including Exrates, TOPBTC, IDEX and HitBTC.

Hot Clean Energy Stocks To Buy Right Now: Catabasis Pharmaceuticals, Inc.(CATB)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Press coverage about Catabasis Pharmaceuticals (NASDAQ:CATB) has been trending somewhat positive recently, according to Accern. The research firm identifies negative and positive press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Catabasis Pharmaceuticals earned a media sentiment score of 0.05 on Accern’s scale. Accern also assigned news articles about the biotechnology company an impact score of 44.9364257314523 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

  • [By Max Byerly]

    These are some of the news articles that may have effected Accern’s analysis:

    Get Catabasis Pharmaceuticals alerts:

    Market Trends Toward New Normal in Church & Dwight Co., Rent-A-Center, Teradata, Catabasis Pharmaceuticals, Tronox, and Callaway Golf — Emerging Consolidated Expectations, Analyst Ratings (finance.yahoo.com) Catabasis Pharmaceuticals Inc. – Receive News & Ratings Daily (thecasualsmart.com) Catabasis Pharmaceuticals (CATB) Upgraded by ValuEngine to Sell (americanbankingnews.com) Catabasis Pharmaceuticals to Report First Quarter 2018 Financial Results and Recent Corporate Developments on Thursday, May 10 (finance.yahoo.com) Catabasis Pharmaceuticals Inc (CATB) Given Consensus Rating of “Buy” by Brokerages (americanbankingnews.com)

    A number of analysts recently issued reports on CATB shares. Zacks Investment Research raised Catabasis Pharmaceuticals from a “hold” rating to a “buy” rating and set a $1.75 target price on the stock in a research report on Friday, January 26th. Wedbush reaffirmed an “outperform” rating and issued a $4.00 target price (down previously from $5.00) on shares of Catabasis Pharmaceuticals in a research report on Wednesday, February 14th. Finally, ValuEngine raised Catabasis Pharmaceuticals from a “strong sell” rating to a “sell” rating in a research report on Wednesday, May 2nd. One analyst has rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the stock. Catabasis Pharmaceuticals presently has a consensus rating of “Buy” and a consensus target price of $5.18.

  • [By Shane Hupp]

    Shares of Catabasis Pharmaceuticals Inc (NASDAQ:CATB) have earned an average recommendation of “Buy” from the seven research firms that are currently covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $3.54.

  • [By Shane Hupp]

    Catabasis Pharmaceuticals Inc (NASDAQ:CATB) traded down 7.2% during trading on Wednesday . The company traded as low as $0.63 and last traded at $0.64. 738,517 shares traded hands during trading, a decline of 6% from the average session volume of 787,009 shares. The stock had previously closed at $0.69.

  • [By Max Byerly]

    Press coverage about Catabasis Pharmaceuticals (NASDAQ:CATB) has been trending somewhat positive recently, Accern reports. The research firm identifies negative and positive media coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Catabasis Pharmaceuticals earned a media sentiment score of 0.14 on Accern’s scale. Accern also gave press coverage about the biotechnology company an impact score of 47.6345851568851 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Hot Clean Energy Stocks To Buy Right Now: Starbucks Corporation(SBUX)

Advisors’ Opinion:

  • [By ]

    Here’s everything you need to know before Monday’s opening bell: 

    Berkshire Hathaway (BRK.A) reported a rare quarterly loss because of an accounting change.  Nestlé will pay Starbucks (SBUX) $7.15 billion for the rights to sell the coffee chain’s products globally. “Avengers: Infinity War” crossed the $1 billion in worldwide box office sales in just 11 days. Investors will analyze earnings from T-Mobile (TMUS) , Zillow (ZG) and more.  U.S. stock futures pushed higher despite a rise in crude oil.  

    Subscribe to our Youtube Channel for extended interviews, Cramer Replays, feature content, and more!

  • [By Paul Ausick]

    While Coke touts the acquisition as a move into the market for hot beverages, it may be the company’s play to gain a toehold in the European market, where it starts in a virtual tie with Starbucks Corp. (NASDAQ: SBUX). Globally, however, Starbucks has more than 27,000 stores. Costa has no stores in the United States.

  • [By Jim Royal]

    Starbucks (NASDAQ:SBUX) is pinning a lot of its growth hopes on China. In time, the country could become the company’s largest market. But for now, the Seattle-based coffee chain is having difficulties, with same-store sales down 2% in the Middle Kingdom last quarter.

  • [By Garrett Baldwin]

    Second, hedge fund manager Bill Ackman announced a $900 million stake in Starbucks Corp. (NASDAQ: SBUX) on Oct. 9.

    Ackman – who already has big stakes in industry giants like Chipotle Mexican Grill Inc. (NYSE: CMG), Restaurant Brands International Inc. (NYSE: QSR), and Mondelez International Inc. (NASDAQ: MDLZ) – predicts that the Seattle coffee chain’s stock could double in just two years.

Hot Clean Energy Stocks To Buy Right Now: Nuveen Massachusetts Premium Income Municipal Fund(NMT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    News articles about Nuveen Massachusetts Pre Income Mun Fd (NYSE:NMT) have been trending somewhat positive this week, according to Accern Sentiment Analysis. The research group ranks the sentiment of media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Nuveen Massachusetts Pre Income Mun Fd earned a daily sentiment score of 0.16 on Accern’s scale. Accern also assigned news stories about the financial services provider an impact score of 47.5987310031013 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Hot Clean Energy Stocks To Buy Right Now: New Century Bancorp Inc.(NC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Whirlpool (NYSE: WHR) and NACCO Industries (NYSE:NC) are both consumer discretionary companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, analyst recommendations and earnings.

Top 10 Low Price Stocks To Buy For 2019

A few weeks ago, we published an article that characterized Gilead (GILD) as a “Value Trap.” That article was a follow-up to an earlier article which used our work on Gilead as an example of how a solid conceptual framework could help investors make better decisions. Both of these articles were based on a 16-page valuation report on Gilead we published to our members in September, 2016.

We caught a lot of flack for the recent characterization of Gilead as a value trap, but our opinion was redeemed on February 7th, when the stock fell heavily after a disappointing earnings announcement.

In today’s article, we’ll take another look at the valuation process – the most important weapon in an investor’s arsenal – in a continuation of the Gilead example. We would invite new readers to read through each of the earlier articles as well, to get a picture of the overall process!

Investing Anecdotes are Dangerous!

What interested us in September 2016, when we made our original analysis of Gilead, was the noise among the value investing community about what a deal Gilead was because the stock was trading at such a low Price-to-Earnings (P/E) ratio (See our article Three Things You Should Know About Gilead).

Top 10 Low Price Stocks To Buy For 2019: USG Corporation(USG)

Advisors’ Opinion:

  • [By Ethan Ryder]

    USG Co. (NYSE:USG) – Equities research analysts at SunTrust Banks reduced their Q3 2018 earnings per share estimates for shares of USG in a report issued on Monday, July 9th. SunTrust Banks analyst K. Hughes now forecasts that the construction company will post earnings of $0.57 per share for the quarter, down from their previous estimate of $0.61. SunTrust Banks currently has a “Hold” rating and a $44.00 price target on the stock. SunTrust Banks also issued estimates for USG’s FY2018 earnings at $2.05 EPS, Q3 2019 earnings at $0.71 EPS and FY2019 earnings at $2.53 EPS.

  • [By Stephan Byrd]

    ValuEngine upgraded shares of USG (NYSE:USG) from a buy rating to a strong-buy rating in a report published on Tuesday.

    A number of other research analysts have also recently weighed in on the stock. Credit Suisse Group upgraded shares of USG from an underperform rating to a neutral rating and dropped their target price for the company from $35.00 to $24.00 in a research note on Friday, April 27th. Jefferies Group reiterated a hold rating and issued a $40.00 target price on shares of USG in a research note on Monday, April 23rd. SunTrust Banks boosted their target price on shares of USG from $42.00 to $44.00 and gave the company a hold rating in a research note on Tuesday, April 17th. Buckingham Research boosted their target price on shares of USG from $34.00 to $42.00 and gave the company a neutral rating in a research note on Monday, April 16th. Finally, Nomura boosted their target price on shares of USG from $39.00 to $44.00 and gave the company a neutral rating in a research note on Tuesday, March 27th. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. The stock currently has a consensus rating of Hold and an average price target of $39.00.

  • [By Jason Hall, George Budwell, and Chuck Saletta]

    And while it may not always work out well to simply copy the moves other investors make, it can pay off to use their buying and selling moves as jumping-off points in your own research. We asked three real-world investors for their insight, and they wrote about two recent Buffett buys ofApple Inc.(NASDAQ:AAPL) andUSG Corporation(NYSE:USG), and a recent Baker Brothers buy ofHeron Therapeutics Inc(NASDAQ:HRTX).

  • [By Jordan Wathen]

    As USG Corporation (NYSE:USG) drags its feet on an offer to sell the company for $42 per share, Berkshire intends to use its 30.8% ownership stake to motivate its top brass to make a deal. Berkshire told Bloomberg it intends to vote its shares against USG’s board members who are up for re-election at this year’s annual meeting, a clear message that Buffett is ready to cash in, even if USG’s management and board are not.

  • [By Dan Caplinger]

    Warren Buffett likes to hold his stock positions for the long run, and his experience with USG (NYSE:USG) has been typical of his other long-term investments. The Oracle of Omaha started buying shares of the manufacturer of Sheetrock drywall and other building materials back in 2000, accumulating a sizable stake that has ballooned to more than 30% of the company. USG ended up going through bankruptcy in order to get a handle on its asbestos liability claims, but thanks largely to Buffett’s involvement, the building materials company not only survived bankruptcy but also saw share prices soar briefly on hopes that USG would once again fully participate in the then-strong housing boom.

Top 10 Low Price Stocks To Buy For 2019: Tekla Healthcare Opportunies Fund(THQ)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Tekla Healthcare Opportunities Fund (NYSE:THQ) declared a monthly dividend on Monday, June 11th, Wall Street Journal reports. Investors of record on Wednesday, June 20th will be paid a dividend of 0.1125 per share on Friday, June 29th. This represents a $1.35 dividend on an annualized basis and a dividend yield of 7.72%. The ex-dividend date of this dividend is Tuesday, June 19th.

Top 10 Low Price Stocks To Buy For 2019: Ampco-Pittsburgh Corporation(AP)

Advisors’ Opinion:

  • [By ]

    New York (AP) — Four more deaths have been linked to a national food poisoning outbreak blamed on tainted lettuce, bringing the total to five.

    Health officials have tied the E. coli outbreak to romaine lettuce grown in Yuma, Arizona. The growing season there ended six weeks ago, and it's unlikely any tainted lettuce is still in stores or people's homes, given its short shelf life. But there can be a lag in reporting, and reports of illnesses have continued to come in.

  • [By ]

    Cayce, S.C. (AP) — A crash between an Amtrak passenger train and a CSX freight train in South Carolina has left at least two people dead and more than 50 injured

  • [By ]

    Wellington, New Zealand (AP) — New Zealand plans to slaughter about 150,000 cows as it tries to eradicate a strain of disease-causing bacteria from the national herd.

  • [By Shane Hupp]

    Deutsche Bank AG boosted its holdings in Ampco-Pittsburgh Corp (NYSE:AP) by 117.3% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 19,599 shares of the industrial products company’s stock after purchasing an additional 10,578 shares during the quarter. Deutsche Bank AG’s holdings in Ampco-Pittsburgh were worth $242,000 at the end of the most recent quarter.

  • [By ]

    Phoenix (AP) — The classified advertising site Backpage.com ignored warnings to stop running advertisements promoting prostitution, sometimes involving children, because the lucrative enterprise brought in half a billion dollars, according to an indictment unsealed Monday.

Top 10 Low Price Stocks To Buy For 2019: BGC Partners, Inc.(BGCP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on BGC Partners (BGCP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    DEUTSCHE BOERSE/ADR (OTCMKTS: DBOEY) and BGC Partners (NASDAQ:BGCP) are both finance companies, but which is the better business? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership.

  • [By ]

    BGC Partners (BGCP) : “We’re in a market where Goldman Sachs (GS) got slammed. I’m going with them.”

    Ecolab (ECL) : “That’s a terrific situation that I want you to buy more of if it comes down.”

  • [By ]

    Cramer was bearish on BGC Partners (BGCP) , Dr Pepper Snapple (DPS) , Sterling Construction Co. Inc.  (STRL) and B&G Foods (BGS) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By Logan Wallace]

    LPL Financial (NASDAQ: LPLA) and BGC Partners (NASDAQ:BGCP) are both mid-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, earnings, dividends and profitability.

  • [By Ethan Ryder]

    UBS Group AG raised its holdings in shares of BGC Partners, Inc. (NASDAQ:BGCP) by 248.2% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,519,131 shares of the financial services provider’s stock after purchasing an additional 1,082,829 shares during the quarter. UBS Group AG’s holdings in BGC Partners were worth $20,432,000 as of its most recent SEC filing.

Top 10 Low Price Stocks To Buy For 2019: The York Water Company(YORW)

Advisors’ Opinion:

  • [By Ethan Ryder]

    BidaskClub downgraded shares of York Water (NASDAQ:YORW) from a hold rating to a sell rating in a research report report published on Thursday.

    Separately, Hilliard Lyons raised shares of York Water from an underperform rating to a neutral rating in a research report on Thursday, March 8th.

Top 10 Low Price Stocks To Buy For 2019: bluebird bio, Inc.(BLUE)

Advisors’ Opinion:

  • [By Brian Orelli]

    On Friday evening, bluebird bio (NASDAQ:BLUE) and Celgene (NASDAQ:CELG) will kick things off with their BCMA-targeted CAR T, bb2121, for patients with multiple myeloma who have failed other treatments. The results from the phase I trial have been impressive so far, albeit in a limited number of patients. The new data should include the expansion cohort of patient treated at the dose to be used in later-stage trials.

  • [By Stephan Byrd]

    bluebird bio (NASDAQ:BLUE) was up 0% during mid-day trading on Thursday . The stock traded as high as $190.50 and last traded at $189.30. Approximately 892,250 shares traded hands during mid-day trading, an increase of 14% from the average daily volume of 779,838 shares. The stock had previously closed at $189.30.

  • [By Ethan Ryder]

    Blue Protocol (CURRENCY:BLUE) traded 5.2% lower against the US dollar during the one day period ending at 18:00 PM ET on June 27th. In the last seven days, Blue Protocol has traded down 29.4% against the US dollar. Blue Protocol has a total market capitalization of $3.16 million and approximately $3,034.00 worth of Blue Protocol was traded on exchanges in the last 24 hours. One Blue Protocol token can currently be bought for approximately $0.0862 or 0.00001406 BTC on exchanges including IDEX, YoBit, CoinExchange and EtherDelta (ForkDelta).

  • [By Motley Fool Staff]

    In his fourth segment — something blue — he talks about clinical-stage gene-therapy company bluebird bio(NASDAQ:BLUE). It’s a RuleBreakers recommendation, and it has been for almost three and a half years. It’s also a fine illustration of some key Foolish principles of investing.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By Brian Orelli]

    bluebird bio (NASDAQ:BLUE) reportedfirst-quarter earnings last week, but like the biotech typically does, management didn’t hold a conference call, which makes the earnings release more of a rehash of the quarter than an actual update.

Top 10 Low Price Stocks To Buy For 2019: Cabot Corporation(CBT)

Advisors’ Opinion:

  • [By Logan Wallace]

    Scopus Asset Management L.P. lifted its position in shares of Cabot Corp (NYSE:CBT) by 74.0% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 435,000 shares of the specialty chemicals company’s stock after buying an additional 185,000 shares during the quarter. Scopus Asset Management L.P.’s holdings in Cabot were worth $24,238,000 at the end of the most recent quarter.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Hertz Global Holdings, Inc. (NYSE: HTZ) is projected to post quarterly loss at $1.31 per share on revenue of $1.97 billion.
    International Flavors & Fragrances Inc. (NYSE: IFF) is estimated to post quarterly earnings at $1.59 per share on revenue of $909.36 million.
    Zillow Group, Inc. (NASDAQ: ZG) is expected to post quarterly earnings at $0.06 per share on revenue of $294.79 million.
    General Cable Corporation (NYSE: BGC) is estimated to post quarterly earnings at $0.15 per share on revenue of $980.61 million.
    Central Garden & Pet Company (NASDAQ: CENT) is expected to post quarterly earnings at $0.84 per share on revenue of $598.45 million.
    Cabot Corporation (NYSE: CBT) is estimated to post quarterly earnings at $1 per share on revenue of $746.42 million.
    Fabrinet (NYSE: FN) is expected to post quarterly earnings at $0.71 per share on revenue of $319.71 million.
    National General Holdings Corp. (NASDAQ: NGHC) is projected to post quarterly earnings at $0.55 per share on revenue of $1.08 billion.
    The Navigators Group, Inc. (NASDAQ: NAVG) is estimated to post quarterly earnings at $0.75 per share on revenue of $320.92 million.
    Diplomat Pharmacy, Inc. (NYSE: DPLO) is expected to post quarterly earnings at $0.22 per share on revenue of $1.29 billion.
    Trex Company, Inc. (NYSE: TREX) is projected to post quarterly earnings at $1.19 per share on revenue of $172.22 million.
    AMC Entertainment Holdings, Inc. (NYSE: AMC) is expected to post quarterly earnings at $0.09 per share on revenue of $1.35 billion.
    Envision Healthcare Corporation (NYSE: EVHC) is projected to post quarterly earnings at $0.64 per share on revenue of $2.02 billion.
    Regal Beloit Corporation (NYSE: RBC) is estimated to post quarterly earnings at $1.23 per share on revenue of $869.64 million.
    Amedisys, Inc. (NASDAQ: AMED) is projected to post quarterly earnings at $0.67 per share on revenue of $39

  • [By Joseph Griffin]

    Sei Investments Co. increased its position in shares of Cabot Corp (NYSE:CBT) by 137.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 69,527 shares of the specialty chemicals company’s stock after acquiring an additional 40,219 shares during the quarter. Sei Investments Co. owned approximately 0.11% of Cabot worth $3,874,000 as of its most recent filing with the Securities and Exchange Commission.

Top 10 Low Price Stocks To Buy For 2019: T-Mobile US, Inc.(TMUS)

Advisors’ Opinion:

  • [By Adam Levy]

    AT&T hopes its bundle can differentiate its product from competitors like Verizon (NYSE:VZ) and T-Mobile (NASDAQ:TMUS), and improve its customer retention. But as it adds more options to the bundle, it could deteriorate its margins without providing meaningful value to many customers.

  • [By ]

    Over on Real Money, Cramer talks about how to trade the highly unlikely deal between Sprint (S) and T-Mobile (TMUS) . Get more of his insights with a free trial subscription to Real Money.

  • [By Paul Ausick]

    The margins for wireless carriers have frayed as Sprint Corp. (NYSE: S), T-Mobile US Inc. (NASDAQ: TMUS), Verizon Communications Inc. (NYSE: VZ) and AT&T play for position among customers in a saturated market. The iPhone 8 still gives them a chance to go after one another with a new chess piece.

  • [By Daniel B. Kline]

    While Sprint (NYSE:S) has an all-stock deal in place to merge with T-Mobile (NASDAQ:TMUS), there are significant doubts that federal regulators will approve it. If that happens, T-Mobile will go back to its fight against Verizon (NYSE:VZ) and AT&T (NYSE:T), with perhaps some added maverick credibility.

Top 10 Low Price Stocks To Buy For 2019: Bovie Medical Corporation(BVX)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares climbed 70.3 percent to $5.45 after reporting 2017 year-end results.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) surged 39.8 percent to $1.58 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) gained 25.6 percent to $11.50. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Aytu Bioscience Inc (NASDAQ: AYTU) shares jumped 21.8 percent to $0.4798 after the company late Monday reported lighter-than-expected Q1 loss.
    Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares gained 21.1 percent to $26.77 following Q3 results.
    Pfenex Inc. (NYSE: PFNX) rose 16.8 percent to $7.1271 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    MEI Pharma, Inc. (NASDAQ: MEIP) rose 13.8 percent to $2.88.
    Red Violet, Inc. (NASDAQ: RDVT) jumped 13.1 percent to $6.41 after reporting Q1 results.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares gained 12 percent to $5.87 after reporting upbeat Q1 results.
    Bovie Medical Corporation (NYSE: BVX) gained 8.4 percent to $3.96 after reporting a first-quarter sales beat.
    Rosehill Resources Inc. (NASDAQ: ROSE) surged 8.4 percent to $7.90 after announcing Q1 results.
    LiqTech International, Inc. (NASDAQ: LIQT) rose 8.1 percent to $0.5171 following Q1 results.
    ProPhase Labs, Inc. (NASDAQ: PRPH) rose 7.7 percent to $5.6103 following Q1 results.
    Nine Energy Service, Inc. (NYSE: NINE) shares climbed 7.4 percent to $35.90.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 6.7 percent to $6.40 after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    MYnd
  • [By Ethan Ryder]

    TheStreet upgraded shares of Bovie Medical (NYSEAMERICAN:BVX) from a d rating to a c- rating in a research report report published on Monday morning.

  • [By Lisa Levin] Gainers
    Red Violet, Inc. (NASDAQ: RDVT) rose 75.31 percent to close at $9.94 after reporting Q1 results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 40.62 percent to close at $4.50 on Tuesday after reporting 2017 year-end results.
    MEI Pharma, Inc. (NASDAQ: MEIP) gained 34.39 percent to close at $3.40.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) gained 32.74 percent to close at $1.50 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Pfenex Inc. (NYSE: PFNX) surged 31.15 percent to close at $8.00 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) rose 21.07 percent to close at $11.09. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Genprex, Inc. (NASDAQ: GNPX) rose 20.23 percent to close at $10.58.
    Turtle Beach Corporation (NASDAQ: HEAR) shares gained 17.62 percent to close at $17.82.
    Aptevo Therapeutics Inc. (NASDAQ: APVO) rose 17.1 percent to close at $5.82.
    Phoenix New Media Limited (NYSE: FENG) shares jumped 16.23 percent to close at $4.87 following Q1 earnings.
    Stein Mart, Inc. (NASDAQ: SMRT) rose 16.04 percent to close at $3.69.
    PPDAI Group Inc. (NASDAQ: PPDF) climbed 15.99 percent to close at $7.98 following Q1 results.
    Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.93 percent to close at $3.42.
    LiqTech International, Inc. (NASDAQ: LIQT) gained 15.59 percent to close at $0.5532 following Q1 results.
    Sophiris Bio, Inc. (NASDAQ: SPHS) gained 13.92 percent to close at $3.52 on Tuesday following Q1 results.
    Euroseas Ltd. (NASDAQ: ESEA) jumped 13.4 percent to close at $2.37.
    Iteris, Inc. (NASDAQ: ITI) shares surged 13.05 percent to close
  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares rose 14.1 percent to $3.65 in the pre-market trading session after reporting 2017 year-end results.
    LightPath Technologies, Inc. (NASDAQ: LPTH) rose 13.3 percent to $2.43 in pre-market trading after reporting a third-quarter earnings beat.
    MYnd Analytics, Inc. (NASDAQ: MYND) rose 10.5 percent to $3.49 in pre-market trading. MYnd Analytics reported a Q2 net loss of $2.7 million on revenue of $459,900.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares rose 8.4 percent to $5.68 in pre-market trading after reporting upbeat Q1 results.
    Famous Dave's of America, Inc. (NASDAQ: DAVE) shares rose 7.7 percent to $8.40 in pre-market trading after the company reported upbeat earnings for its first quarter on Monday.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 7.5 percent to $6.45 in pre-market trading after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    Mimecast Ltd (NASDAQ: MIME) rose 6.5 percent to $43.50 in pre-market trading following a first-quarter sales beat.
    Boxlight Corporation (NASDAQ: BOXL) rose 6 percent to $12.50 in pre-market trading after surging 77.44 percent on Monday.
    Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares rose 6 percent to $26.05 in pre-market trading after climbing 3.58 percent on Monday.
    PPDAI Group Inc. (NASDAQ: PPDF) rose 4.7 percent to $7.20 in pre-market trading following Q1 results.
    Xunlei Limited (NASDAQ: XNET) rose 4.1 percent to $13.88 in pre-market trading after gaining 2.54 percent on Monday.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 4.5 percent to $21.73 in pre-market trading. Mizuho upgraded Valeant from Neutral to Buy.
    Bovie Medical Corporation (NYSE: BVX) rose 4.1 percent to $3.80 in pre-market trading after reporting a first-quarter sales beat.
    Myomo, Inc. (NYSE: MYO) rose 3.4 percent to $4.00 in pre-market trading after jumping 23.25 percent o

Top 10 Low Price Stocks To Buy For 2019: Gladstone Commercial Corporation(GOOD)

Advisors’ Opinion:

  • [By Max Byerly]

    Goodomy (GOOD) is a PoW/PoS token that uses the Scrypt hashing algorithm. Its genesis date was June 21st, 2017. Goodomy’s total supply is 888,000,000 tokens and its circulating supply is 620,508,777 tokens. Goodomy’s official Twitter account is @GoodKarmaCoin and its Facebook page is accessible here. Goodomy’s official website is goodomy.com.

  • [By Shane Hupp]

    Goodomy (GOOD) is a PoW/PoS token that uses the Scrypt hashing algorithm. Its launch date was June 21st, 2017. Goodomy’s total supply is 888,000,000 tokens and its circulating supply is 620,508,777 tokens. Goodomy’s official Twitter account is @GoodKarmaCoin and its Facebook page is accessible here. Goodomy’s official website is goodomy.com.

Top 10 Value Stocks To Invest In Right Now

Whole Foods Market (NASDAQ:WFM) has had a bad time on the market over the past couple of months, losing over 16% of its value on the back of a weak financial performance in its last reported quarter. But, in my opinion, the recent drop in Whole Foods’ shares is an opportunity to buy more of the stock since there are tangible improvements being witnessed across Whole Foods’ operations as discussed in this article. Let’s take a look.

Sales building initiatives are delivering results

Whole Foods Market’s focus on improving its sales is delivering results, slowly but steadily. For instance, its comparable store sales dropped 2.6% last quarter as compared to a decline of 3% in the preceding quarter. More importantly, Whole Foods is witnessing an improvement in its comparable store sales this quarter as well, as the rate of decline of its comp sales has gone down to 2.4% in the first three weeks of the 12-week fourth quarter.

In addition, the company expects square footage growth of 7% in 2016 and approximately 6% in 2017, driven by the addition of new stores to its portfolio that continue to witness positive comp sales growth. For instance, last quarter, Whole Foods opened 12 new stores that include its first 365 Store. The company has opened one 365 and two Whole Foods Market stores in the ongoing quarter, and it plans to open two additional stores, including one 365 and two Whole Foods Market stores.

Top 10 Value Stocks To Invest In Right Now: CBOE Holdings Inc.(CBOE)

Advisors’ Opinion:

  • [By Dustin Blitchok]

    After CBOE Global Markets Inc (NASDAQ: CBOE) launched bitcoin futures in December, Charles Schwab Corporation (NYSE: SCHW) didn't immediately make the product available to clients, said Barry Metzger, the brokerage’s senior vice president of global, trading and advice.

  • [By Max Byerly]

    Deutsche B枚rse (OTCMKTS: DBOEY) and Cboe Global Markets (NASDAQ:CBOE) are both large-cap finance companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, risk, dividends, institutional ownership, profitability, valuation and analyst recommendations.

  • [By Dan Caplinger]

    Last December, two major futures exchanges started offering futures contracts on bitcoin. CBOE Global Markets (NASDAQ:CBOE) was the first to market with its futures offering, and CME Group (NASDAQ:CME) didn’t waste any time coming out with its own version of a bitcoin contract.

  • [By Asit Sharma]

    Cboe Global Markets, Inc. (NASDAQ:CBOE) reported expansive earnings growth in its first-quarter 2018 report, issued on May 3. In addition to revenue tacked on from its acquisition of Bats Global Markets in March 2017, Cboe enjoyed increased volume in trading of the company’s proprietary VIX (Cboe Volatility Index) futures and options.

  • [By Sean Williams]

    But times have changed, the virtual-currency market has matured a bit, and institutional investors have had a means to bet on the crypto market in a more traditional sense over the past couple of months. By this, I mean that both the CME Groupand CBOE Global Markets (NASDAQ:CBOE) have offered bitcoin futures on their trading platforms since December, providing a more traditional avenue for Wall Street to place its bets.

Top 10 Value Stocks To Invest In Right Now: Prudential Public Limited Company(PUK)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Here are some of the news headlines that may have effected Accern’s rankings:

    Get Prudential alerts:

    Zacks Investment Research Lowers Prudential (PUK) to Hold (americanbankingnews.com) Financial wellness program popularity rises among employers, up 63 percentage points in two years (markets.financialcontent.com) FY2018 EPS Estimates for Prudential (PUK) Reduced by Jefferies Group (americanbankingnews.com) Jefferies Group Weighs in on Prudential’s FY2020 Earnings (PUK) (americanbankingnews.com) ValuEngine Downgrades Prudential (PUK) to Hold (americanbankingnews.com)

    Shares of PUK stock traded down $0.02 during trading on Tuesday, hitting $51.56. 141,455 shares of the stock traded hands, compared to its average volume of 198,097. The firm has a market cap of $66.49 billion, a PE ratio of 13.79, a PEG ratio of 1.34 and a beta of 1.55. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.03 and a current ratio of 0.03. Prudential has a 52-week low of $44.49 and a 52-week high of $55.36.

  • [By Ethan Ryder]

    ValuEngine lowered shares of Prudential (NYSE:PUK) from a buy rating to a hold rating in a research note issued to investors on Wednesday morning.

    Several other analysts have also recently issued reports on the stock. Zacks Investment Research upgraded shares of Prudential from a hold rating to a buy rating and set a $57.00 target price on the stock in a research note on Tuesday, March 27th. Berenberg Bank cut shares of Prudential from a hold rating to a sell rating in a research note on Thursday, March 29th. Finally, Citigroup cut shares of Prudential from a buy rating to a neutral rating in a research note on Wednesday, April 25th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the company. The stock currently has an average rating of Hold and an average price target of $57.00.

  • [By Ethan Ryder]

    Prudential (NYSE: PUK) and Reinsurance Group of America (NYSE:RGA) are both finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, risk, profitability and institutional ownership.

Top 10 Value Stocks To Invest In Right Now: Aspen Insurance Holdings Limited(AHL)

Advisors’ Opinion:

  • [By Ethan Ryder]

    The Travelers Companies (NYSE: TRV) and Aspen Insurance (NYSE:AHL) are both finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, profitability, analyst recommendations, valuation, earnings and risk.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Aspen Insurance (AHL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Value Stocks To Invest In Right Now: Lifetime Brands Inc.(LCUT)

Advisors’ Opinion:

  • [By Logan Wallace]

    Stanley Black & Decker (NYSE: SWK) and Lifetime Brands (NASDAQ:LCUT) are both industrial products companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, analyst recommendations, profitability, earnings and risk.

Top 10 Value Stocks To Invest In Right Now: Sarepta Therapeutics, Inc.(SRPT)

Advisors’ Opinion:

  • [By Max Byerly]

    Sarepta Therapeutics (NASDAQ:SRPT) had its target price increased by Morgan Stanley from $87.00 to $91.00 in a report issued on Friday. Morgan Stanley currently has an equal weight rating on the biotechnology company’s stock.

  • [By Keith Speights]

    But some stocks don’t take nearly that long to double. Three stocks in particularhave doubled investors’ money — and more — in just the last 12 months. Here’s why Nektar Therapeutics (NASDAQ:NKTR), CRISPR Therapeutics (NASDAQ:CRSP), and Sarepta Therapeutics (NASDAQ:SRPT) became such huge winners — and whether or not their impressive momentum can continue.

  • [By Brian Feroldi]

    After reporting first-quarter results, shares of Sarepta Therapeutics(NASDAQ:SRPT), acommercial-stage biotech focused on rare diseases, jumped 14% as of 3:40 p.m. EDT Friday.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Sarepta Therapeutics (SRPT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Barclays upgraded shares of Sarepta Therapeutics (NASDAQ:SRPT) from an equal weight rating to an overweight rating in a research report released on Friday morning, MarketBeat.com reports. They currently have $107.00 target price on the biotechnology company’s stock, up from their prior target price of $55.00.

  • [By Stephan Byrd]

    Trexquant Investment LP acquired a new position in Sarepta Therapeutics (NASDAQ:SRPT) in the first quarter, Holdings Channel reports. The institutional investor acquired 7,135 shares of the biotechnology company’s stock, valued at approximately $529,000.

Top 10 Value Stocks To Invest In Right Now: Tarena International, Inc.(TEDU)

Advisors’ Opinion:

  • [By Max Byerly]

    K12 (NYSE: LRN) and Tarena International (NASDAQ:TEDU) are both small-cap consumer discretionary companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

  • [By Ethan Ryder]

    Tarena International (NASDAQ: TEDU) and TAL Education (NYSE:TAL) are both business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends and institutional ownership.

Top 10 Value Stocks To Invest In Right Now: DHX Media Ltd.(DHXM)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Turtle Beach Corporation (NASDAQ: HEAR) surged 87.1 percent to $12.98 after the company reported Q1 results and raised its FY18 outlook.
    ARMO BioSciences, Inc. (NASDAQ: ARMO) shares jumped 66.8 percent to $49.735 after Eli Lilly and Company (NYSE: LLY) announced plans to acquire ARMO BioSciences for $50 per share.
    vTv Therapeutics Inc. (NASDAQ: VTVT) gained 34 percent to $2.2920 following announcement that the company will pre-specify new subgroup with the FDA and report Phase 3 Part B results in June.
    Prestige Brands Holdings, Inc. (NYSE: PBH) climbed 22.3 percent to $34.84 after the company posted upbeat Q4 earnings.
    Depomed, Inc. (NASDAQ: DEPO) shares jumped 22.2 percent to $7.28 following better-than-expected Q1 earnings.
    Everspin Technologies, Inc. (NASDAQ: MRAM) gained 19.8 percent to $8.89 after the company reported strong results for its first quarter.
    Luxfer Holdings PLC (NYSE: LXFR) surged 19.8 percent to $17.10 following Q1 results.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 18.3 percent to $2.26 after French company Total announced plans to acquire 25 percent stake in Clean Energy Fuels for $83.4 million.
    Intelligent Systems Corporation (NYSE: INS) gained 17 percent to $7.116.
    Green Dot Corporation (NYSE: GDOT) surged 15.3 percent to $73.00 after reporting upbeat Q1 earnings.
    The Chefs' Warehouse, Inc. (NASDAQ: CHEF) climbed 15 percent to $28.85. Chefs' Warehouse posted Q1 earnings of $0.03 per share on sales of $318.6 million.
    Westport Fuel Systems Inc. (NASDAQ: WPRT) rose 14.2 percent to $2.9701.
    Wright Medical Group N.V. (NASDAQ: WMGI) jumped 13.8 percent to $23.87 after reporting upbeat quarterly earnings.
    Diplomat Pharmacy, Inc. (NYSE: DPLO) gained 13.4 percent to $22.70. Diplomat named Brian Griffin as Chairman and CEO.
    Carvana Co. (NYSE: CVNA) shares rose 13 percent to $27.97 after reporting upbeat Q1 sales.
    Prothena Corporation plc (NASDAQ: PRTA) gained 12 percent to $15.19
  • [By Anders Bylund]

    Family-friendly media company DHX Media (NASDAQ:DHXM) reported third-quarter earnings early Monday morning. Investors didn’t see much to like in this business update, and the stock closed 19.7% lower at the end of the day.

  • [By Dan Caplinger]

    The stock market had a generally solid performance on Monday, with large-cap indexes posting modest gains even as benchmarks that track the changes of smaller stocks underperformed. The big news of the day came on the trade front, where the White House intervened to reverse previous policy with respect to Chinese smartphone giant ZTE in an apparent effort to gain favor with the world’s most populous nation and second-largest economic power. Investors looked for potential winners from the thawing of relations with China, but not all stocks were able to avoid significant losses. Viacom (NASDAQ:VIAB), Synchronoss Technologies (NASDAQ:SNCR), and DHX Media (NASDAQ:DHXM) were among the worst performers on the day. Here’s why they did so poorly.

Top 10 Value Stocks To Invest In Right Now: BGC Partners, Inc.(BGCP)

Advisors’ Opinion:

  • [By ]

    Cramer was bearish on BGC Partners (BGCP) , Dr Pepper Snapple (DPS) , Sterling Construction Co. Inc.  (STRL) and B&G Foods (BGS) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By ]

    BGC Partners (BGCP) : “We’re in a market where Goldman Sachs (GS) got slammed. I’m going with them.”

    Ecolab (ECL) : “That’s a terrific situation that I want you to buy more of if it comes down.”

  • [By Logan Wallace]

    LPL Financial (NASDAQ: LPLA) and BGC Partners (NASDAQ:BGCP) are both mid-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, earnings, dividends and profitability.

Top 10 Value Stocks To Invest In Right Now: Haverty Furniture Companies, Inc.(HVT)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Havertys (NYSE:HVT) – Stock analysts at KeyCorp dropped their Q2 2018 earnings per share estimates for Havertys in a research report issued on Wednesday, May 2nd. KeyCorp analyst B. Thomas now anticipates that the company will post earnings per share of $0.29 for the quarter, down from their previous forecast of $0.31. KeyCorp also issued estimates for Havertys’ Q3 2018 earnings at $0.39 EPS and Q4 2018 earnings at $0.45 EPS.

Top 10 Value Stocks To Invest In Right Now: CrossAmerica Partners LP(CAPL)

Advisors’ Opinion:

  • [By Joseph Griffin]

    CrossAmerica Partners (NYSE:CAPL) last released its quarterly earnings data on Monday, February 26th. The oil and gas company reported $0.06 EPS for the quarter, hitting the consensus estimate of $0.06. CrossAmerica Partners had a return on equity of 4.73% and a net margin of 0.84%. The company had revenue of $552.66 million during the quarter, compared to the consensus estimate of $572.48 million. sell-side analysts anticipate that CrossAmerica Partners will post 0.24 EPS for the current year.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on CrossAmerica Partners (CAPL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    CrossAmerica Partners (NYSE:CAPL) – Research analysts at Jefferies Group reduced their FY2018 earnings estimates for CrossAmerica Partners in a research note issued to investors on Wednesday, May 9th. Jefferies Group analyst C. Mandeville now forecasts that the oil and gas company will earn $0.24 per share for the year, down from their previous forecast of $0.32. Jefferies Group currently has a “Buy” rating and a $28.00 target price on the stock. Jefferies Group also issued estimates for CrossAmerica Partners’ Q1 2019 earnings at $0.07 EPS, Q2 2019 earnings at $0.13 EPS, Q4 2019 earnings at $0.14 EPS and FY2020 earnings at $0.42 EPS.